Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125369241 | 12536924 | 1 | I | 20160621 | 20160707 | 20160707 | EXP | CN-JNJFOC-20160621149 | JANSSEN | LIU Q, ZHANG HY, CAO QJ, SHUANG M, YANG FD, WANG CY, ET AL. EFFICACY AND TOLERABILITY OF DOMESTIC BLONANSERIN TABLETS IN ACUTE SCHIZOPHRENIC: A RANDOMIZED, DOUBLE-BLIND, RISPERIDONE-CONTROLLED TRIAL. CHINESE JOURNAL OF NEW DRUGS 15-APR-2016;25 (7):779-786. | 0.00 | Y | 0.00000 | 20160707 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125369241 | 12536924 | 1 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | DOSE: 2-6 MG PER DAY FOR 8 WEEKS; TWO DOSES AFTER MEALS. | U | U | 0 | TABLETS | |||||||
| 125369241 | 12536924 | 2 | PS | RISPERIDONE. | RISPERIDONE | 1 | Oral | DOSE REDUCED IN WEEK 9 | U | U | 20272 | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125369241 | 12536924 | 1 | Schizophrenia |
| 125369241 | 12536924 | 2 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125369241 | 12536924 | HO |
| 125369241 | 12536924 | LT |
| 125369241 | 12536924 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125369241 | 12536924 | Alanine aminotransferase increased | |
| 125369241 | 12536924 | Aspartate aminotransferase increased | |
| 125369241 | 12536924 | Asthenia | |
| 125369241 | 12536924 | Blood pressure decreased | |
| 125369241 | 12536924 | Blood pressure increased | |
| 125369241 | 12536924 | Bradycardia | |
| 125369241 | 12536924 | Constipation | |
| 125369241 | 12536924 | Electrocardiogram QT prolonged | |
| 125369241 | 12536924 | Electrocardiogram abnormal | |
| 125369241 | 12536924 | Epilepsy | |
| 125369241 | 12536924 | Extrapyramidal disorder | |
| 125369241 | 12536924 | Galactorrhoea | |
| 125369241 | 12536924 | Hepatic function abnormal | |
| 125369241 | 12536924 | Hyperprolactinaemia | |
| 125369241 | 12536924 | Leukopenia | |
| 125369241 | 12536924 | Menstrual disorder | |
| 125369241 | 12536924 | Nausea | |
| 125369241 | 12536924 | Palpitations | |
| 125369241 | 12536924 | Rash | |
| 125369241 | 12536924 | Suicide attempt | |
| 125369241 | 12536924 | Tachycardia | |
| 125369241 | 12536924 | Treatment noncompliance | |
| 125369241 | 12536924 | Vomiting | |
| 125369241 | 12536924 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |